-
Je něco špatně v tomto záznamu ?
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
A. Rehulkova, J. Chudacek, A. Prokopova, M. Vidlarova, J. Stranska, J. Drabek, J. Potockova, R. Trojanec, J. Vrbkova, J. Skarda, T. Bohanes, M. Szkorupa, B. Tolmaci, J. Klein, J. Srovnal, M. Hajduch
Status neindexováno Jazyk angličtina Země Čína
Typ dokumentu časopisecké články
Odkazy
PubMed
37323172
DOI
10.21037/tlcr-22-801
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Surgical treatment of early-stage non-small cell lung cancer (NSCLC) yields highest expectations for recovery. However, the frequency of further disease progression remains high since micro-metastatic disease may be undetected by conventional diagnostic methods. We test the presence and prognostic impact of circulating tumor cells (CTCs) in peripheral blood (PB), tumor-draining pulmonary blood (TDB) and bone marrow (BM) samples from NSCLC patients. METHODS: The presence of circulating/disseminated tumor cells (CTCs/DTCs) was detected by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis in PB, TDB and BM samples before surgery in 119 stage IA-IIIA NSCLC patients (Clinical Trial NS10285). RESULTS: NSCLC patients with the presence of carcinoembryonic antigen (CEA) mRNA-positive CTCs/DTCs in TDB and BM had significantly shorter cancer-specific survival (CSS) (P<0.013, resp. P<0.038). Patients with the presence of epithelial cellular adhesion molecule (EpCAM) mRNA-positive CTCs in TDB samples had significantly shorter CSS and disease-free survival (DFS) (P<0.031, resp. P<0.045). A multivariate analysis identified the presence of CEA mRNA-positive CTCs in the PB as an independent negative prognostic factor for DFS (P<0.005). No significant correlation of CTCs/DTCs presence and other prognostic factors was found. CONCLUSIONS: In NSCLC patients undergoing radical surgery, the presence of CEA and EpCAM mRNA-positive CTCs/DTCs is associated with poorer survival.
Cancer Research Czech Republic Olomouc Czech Republic
Department of Surgery Tomas Bata Regional Hospital Zlin Czech Republic
Department of Thoracic Surgery Clinic Floridsdorf Vienna Austria
Faculty of Healthcare Alexander Dubcek University of Trencin Trencin Slovakia
Laboratory of Experimental Medicine University Hospital in Olomouc Olomouc Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009664
- 003
- CZ-PrNML
- 005
- 20240206140117.0
- 007
- ta
- 008
- 230707s2023 cc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21037/tlcr-22-801 $2 doi
- 035 __
- $a (PubMed)37323172
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a cc
- 100 1_
- $a Rehulkova, Alona $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, University Hospital in Olomouc, Olomouc, Czech Republic $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic $u Department of Surgery, Tomas Bata Regional Hospital, Zlin, Czech Republic
- 245 10
- $a Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients / $c A. Rehulkova, J. Chudacek, A. Prokopova, M. Vidlarova, J. Stranska, J. Drabek, J. Potockova, R. Trojanec, J. Vrbkova, J. Skarda, T. Bohanes, M. Szkorupa, B. Tolmaci, J. Klein, J. Srovnal, M. Hajduch
- 520 9_
- $a BACKGROUND: Surgical treatment of early-stage non-small cell lung cancer (NSCLC) yields highest expectations for recovery. However, the frequency of further disease progression remains high since micro-metastatic disease may be undetected by conventional diagnostic methods. We test the presence and prognostic impact of circulating tumor cells (CTCs) in peripheral blood (PB), tumor-draining pulmonary blood (TDB) and bone marrow (BM) samples from NSCLC patients. METHODS: The presence of circulating/disseminated tumor cells (CTCs/DTCs) was detected by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis in PB, TDB and BM samples before surgery in 119 stage IA-IIIA NSCLC patients (Clinical Trial NS10285). RESULTS: NSCLC patients with the presence of carcinoembryonic antigen (CEA) mRNA-positive CTCs/DTCs in TDB and BM had significantly shorter cancer-specific survival (CSS) (P<0.013, resp. P<0.038). Patients with the presence of epithelial cellular adhesion molecule (EpCAM) mRNA-positive CTCs in TDB samples had significantly shorter CSS and disease-free survival (DFS) (P<0.031, resp. P<0.045). A multivariate analysis identified the presence of CEA mRNA-positive CTCs in the PB as an independent negative prognostic factor for DFS (P<0.005). No significant correlation of CTCs/DTCs presence and other prognostic factors was found. CONCLUSIONS: In NSCLC patients undergoing radical surgery, the presence of CEA and EpCAM mRNA-positive CTCs/DTCs is associated with poorer survival.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chudacek, Josef $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Prokopova, Andrea $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Vidlarova, Monika $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Stranska, Jana $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, University Hospital in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Drabek, Jiri $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, University Hospital in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Potockova, Jana $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Trojanec, Radek $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Vrbková, Jana, $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $d 1971- $7 xx0105359
- 700 1_
- $a Skarda, Josef $u Institute of Molecular and Clinical Pathology and Medical Genetics, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Bohanes, Tomas $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic $u Department of Thoracic Surgery, Clinic Floridsdorf, Vienna, Austria
- 700 1_
- $a Szkorupa, Marek $u Department of Surgery, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Tolmaci, Benjamin $u Department of Surgery, Tomas Bata Regional Hospital, Zlin, Czech Republic
- 700 1_
- $a Klein, Jiri $u Department of Surgery, Tomas Bata Regional Hospital, Zlin, Czech Republic $u Faculty of Healthcare, Alexander Dubcek University of Trencin, Trencin, Slovakia
- 700 1_
- $a Srovnal, Josef $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, University Hospital in Olomouc, Olomouc, Czech Republic $u Cancer Research Czech Republic, Olomouc, Czech Republic
- 700 1_
- $a Hajduch, Marian $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University in Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, University Hospital in Olomouc, Olomouc, Czech Republic $u Cancer Research Czech Republic, Olomouc, Czech Republic
- 773 0_
- $w MED00186389 $t Translational lung cancer research $x 2218-6751 $g Roč. 12, č. 5 (2023), s. 1034-1050
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37323172 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20240206140114 $b ABA008
- 999 __
- $a ok $b bmc $g 1958458 $s 1195928
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 12 $c 5 $d 1034-1050 $e 20230417 $i 2218-6751 $m Translational lung cancer research $n Transl Lung Cancer Res $x MED00186389
- LZP __
- $a Pubmed-20230707